Pluri Stock Approaches Critical Juncture

Expansion Strategy Gains Momentum

Pluri Inc. finds itself at a pivotal moment as the biotechnology firm prepares to release quarterly results on Monday. With shares currently trading at $3.29, the upcoming financial report could deliver the next significant catalyst for the stock’s movement.

The company is aggressively advancing its agricultural technology initiatives, most recently through its subsidiary Coffeesai’s collaboration with the Instituto del Café de Chiapas. This partnership targets the multi-billion dollar global coffee market through a three-phase approach:

• Establishing cell lines specifically for coffee production
• Implementing pilot production using 3D bioreactors
• Assessing commercial scalability potential